Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Install
Faster access than browser!
 

Befiradol

+ Save concept

Befiradol (F-13,640; NLX-112) is a very potent and highly selective 5-HT1A receptor full agonist. [1]

24 relations: Adenylyl cyclase, Adverse effect, Agonist, Allodynia, Analgesic, Benzothiophene, Binding selectivity, Drug tolerance, Eptapirone, Extracellular signal–regulated kinases, F-15,599, Flesinoxan, G alpha subunit, G protein, Laboratoires Pierre Fabre, Levodopa-induced dyskinesia, Neurolixis, Opioid, Parkinson's disease, Parkinson's UK, Potency (pharmacology), Receptor-mediated endocytosis, The Michael J. Fox Foundation, 5-HT1A receptor.

Adenylyl cyclase

Adenylyl cyclase (also commonly known as adenyl cyclase and adenylate cyclase, abbreviated AC) is an enzyme with key regulatory roles in essentially all cells.

New!!: Befiradol and Adenylyl cyclase · See more »

Adverse effect

In medicine, an adverse effect is an undesired harmful effect resulting from a medication or other intervention such as surgery.

New!!: Befiradol and Adverse effect · See more »

Agonist

An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.

New!!: Befiradol and Agonist · See more »

Allodynia

Allodynia (Ancient Greek άλλος állos "other" and οδύνη odúnē "pain") refers to central pain sensitization (increased response of neurons) following normally non-painful, often repetitive, stimulation.

New!!: Befiradol and Allodynia · See more »

Analgesic

An analgesic or painkiller is any member of the group of drugs used to achieve analgesia, relief from pain.

New!!: Befiradol and Analgesic · See more »

Benzothiophene

Benzothiophene is an aromatic organic compound with a molecular formula C8H6S and an odor similar to naphthalene (mothballs).

New!!: Befiradol and Benzothiophene · See more »

Binding selectivity

Binding selectivity is defined with respect to the binding of ligands to a substrate forming a complex.

New!!: Befiradol and Binding selectivity · See more »

Christmas

Christmas is an annual festival commemorating the birth of Jesus Christ,Martindale, Cyril Charles.

New!!: Befiradol and Christmas · See more »

Christmas and holiday season

The Christmas season, also called the festive season, or the holiday season (mainly in the U.S. and Canada; often simply called the holidays),, is an annually recurring period recognized in many Western and Western-influenced countries that is generally considered to run from late November to early January.

New!!: Befiradol and Christmas and holiday season · See more »

Christmas Eve

Christmas Eve is the evening or entire day before Christmas Day, the festival commemorating the birth of Jesus.

New!!: Befiradol and Christmas Eve · See more »

Christmas traditions

Christmas traditions vary from country to country.

New!!: Befiradol and Christmas traditions · See more »

Drug tolerance

Drug tolerance is a pharmacological concept describing subjects' reduced reaction to a drug following its repeated use.

New!!: Befiradol and Drug tolerance · See more »

Eptapirone

Eptapirone (F-11,440) is a very potent and highly selective 5-HT1A receptor full agonist of the azapirone family.

New!!: Befiradol and Eptapirone · See more »

Extracellular signal–regulated kinases

In molecular biology, extracellular signal–regulated kinases (ERKs) or classical MAP kinases are widely expressed protein kinase intracellular signalling molecules that are involved in functions including the regulation of meiosis, mitosis, and postmitotic functions in differentiated cells.

New!!: Befiradol and Extracellular signal–regulated kinases · See more »

F-15,599

F-15,599, also known as NLX-101, is a very potent and highly selective 5-HT1A receptor full agonist.

New!!: Befiradol and F-15,599 · See more »

Flesinoxan

Flesinoxan (DU-29,373) is a potent and selective 5-HT1A receptor partial/near-full agonist of the phenylpiperazine class.

New!!: Befiradol and Flesinoxan · See more »

G alpha subunit

Guanine nucleotide binding proteins (G proteins) are membrane-associated, heterotrimeric proteins composed of three subunits: alpha, beta, and gamma.

New!!: Befiradol and G alpha subunit · See more »

G protein

G proteins, also known as guanine nucleotide-binding proteins, are a family of proteins that act as molecular switches inside cells, and are involved in transmitting signals from a variety of stimuli outside a cell to its interior.

New!!: Befiradol and G protein · See more »

Laboratoires Pierre Fabre

Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company.

New!!: Befiradol and Laboratoires Pierre Fabre · See more »

Levodopa-induced dyskinesia

Levodopa-induced dyskinesia is a form of dyskinesia associated with levodopa, used to treat Parkinson's disease.

New!!: Befiradol and Levodopa-induced dyskinesia · See more »

Neurolixis

Neurolixis is a biopharmaceutical company focused on novel drugs for the treatment of human central nervous system diseases.

New!!: Befiradol and Neurolixis · See more »

New Year

New Year is the time or day at which a new calendar year begins and the calendar's year count increments by one.

New!!: Befiradol and New Year · See more »

New Year's Day

New Year's Day, also called simply New Year's or New Year, is observed on January 1, the first day of the year on the modern Gregorian calendar as well as the Julian calendar.

New!!: Befiradol and New Year's Day · See more »

New Year's Eve

In the Gregorian calendar, New Year's Eve (also known as Old Year's Day or Saint Sylvester's Day in many countries), the last day of the year, is on 31 December which is the seventh day of Christmastide.

New!!: Befiradol and New Year's Eve · See more »

Opioid

Opioids are substances that act on opioid receptors to produce morphine-like effects.

New!!: Befiradol and Opioid · See more »

Parkinson's disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

New!!: Befiradol and Parkinson's disease · See more »

Parkinson's UK

Parkinson's UK is a Parkinson's research and support charity in the United Kingdom.

New!!: Befiradol and Parkinson's UK · See more »

Potency (pharmacology)

In the field of pharmacology, potency is a measure of drug activity expressed in terms of the amount required to produce an effect of given intensity.

New!!: Befiradol and Potency (pharmacology) · See more »

Receptor-mediated endocytosis

Receptor-mediated endocytosis (RME), also called clathrin-mediated endocytosis, is a process by which cells absorb metabolites, hormones, other proteins – and in some cases viruses – by the inward budding of plasma membrane vesicles containing proteins with receptor sites specific to the molecules being absorbed (endocytosis).

New!!: Befiradol and Receptor-mediated endocytosis · See more »

The Michael J. Fox Foundation

The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease (PD) through funded research and ensuring the development of improved therapies for those living with Parkinson's today.

New!!: Befiradol and The Michael J. Fox Foundation · See more »

2018

2018 has been designated as the third International Year of the Reef by the International Coral Reef Initiative.

New!!: Befiradol and 2018 · See more »

2019

2019 (MMXIX) will be a common year starting on Tuesday of the Gregorian calendar, the 2019th year of the Common Era (CE) and Anno Domini (AD) designations, the 19th year of the 3rd millennium, the 19th year of the 21st century, and the 10th and last year of the 2010s decade.

New!!: Befiradol and 2019 · See more »

5-HT1A receptor

The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

New!!: Befiradol and 5-HT1A receptor · See more »

Redirects here:

C20H22ClF2N3O, F 13640, F-13,640, F-13640, F13640.

References

[1] https://en.wikipedia.org/wiki/Befiradol

OutgoingIncoming
Hey! We are on Facebook now! »